Skip to main content
OpenTrials
Completed

NCT Number: NCT02282007

Norwegian Psychomotor Physiotherapy - The Effect on Quality of Life

More and more people suffer from stress-related illness and ailments that can greatly affect the individual's experienced quality of life and sense of coping since pain, physical, mental and social functioning are closely linked. Many of these people will seek primary care for help, and thus be referred to the Norwegian psychomotor physiotherapy (NPMP) performed by physiotherapists in primary care.

Data shows that for the first three months of 2009, 42% of patients were referred to NPMP had a musculoskeletal diagnosis as the first diagnosis, often in the form of long-term and comprehensive pain problems. Many of the patients also had emotional difficulties, but without being diagnosed with mental illness. 23% of patients who were referred to NPMP had a psychiatric diagnosis as the first diagnosis. The full range of psychiatric diagnoses are represented, but the majority of patients were treated for anxiety and depression.

The investigators want to let people who have had NPMP treatment to consider what effect the treatment has given, measured by separate registrations of quality of life, pain, physical, mental and social functioning.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pain Muscle Skeletal Disorders Neurologic Manifestations Pathological Conditions, Signs and Symptoms Psychosomatic Diseases Signs and Symptoms Stress

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

HIOA, Oslo, Norway

Loading trial locations.

About this study

The primary aim of this is project intends to evaluate the effect of Norwegian psychomotor physiotherapy (NPMP) on Health related Quality of Life measured by Short-form Health Survey (SF-36). The secondary aims are to evaluate the effect of Norwegian psychomotor physiotherapy (NPMP) on the variables Subjective Health Complaints Inventory (SHC); Hopkins 's Symptom Check List , Örebro Screening for musculo-skeletal pain ,Numeric Pain Rating Scale , Oslo Social Support Scale , Coping and The self-esteem scale"

The study design is based on the guidelines for randomized controlled trials presented in the CONSORT statement. The study will address to people who have had NPMP treatment approach, and they will be asked to consider what effect the treatment has given, measured by separate registrations of quality of life, pain, physical, mental and social functioning.

Participants Power calculation based on the primary outcome Short-form Health Survey (SF-36) proved that minimum 170 participants must be recruited. The participants will be recruited among patients on the waiting list for NPMP by all psychomotor physiotherapists who are members of the Norwegian Physiotherapists Association. If patients want to participate in the study, they will be randomized to an intervention group and a control group by drawing lots.

The intervention group will have NPMP as usual in 6 months. The control group remains on the waiting list for 6 months. Participants in both groups will be asked to fill out the self-assessment questionnaire at the start of the project and at the completion of the project after six months. Participants in the intervention group will receive the same form after 12 months, to examine whether there have been any subsequent change after completion NPMF.

Timing of surveys:

Participants will be given questionnaires by the NPMP physiotherapist at

  • Baseline - 2 weeks before NPMF (both groups)
  • After 6 months (both groups)
  • After 12 months (intervention group).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being referred to NPMP
  • Being able to give informed consent
  • The therapist finds the NPMP to be a proper treatment to this patient

Exclusion criteria

  • Do not understand Norwegian

Treatment and study plan

Individual NPMP to the participants

Behavioral

The participants in the intervention group will receive NPMP individually adjusted for six months. NPMP is not a standardized treatment approach, but individually adjusted to the individual patient according to their individual problems.

Primary outcomes

  1. Change from baseline in Short-form Health Survey (SF-36) at 6 months

    Time frame: 6 months

    This will be assessed for both the control group and the intervention group.

  2. Change from baseline in Short-form Health Survey (SF-36) at 12 months

    Time frame: 12 months

    This outcome measure will be assessed only for the intervention group.

Secondary outcomes

  1. Change from baseline in Subjective Health Complaints Inventory (SHC) at 6 months

    Time frame: 6 months

    This will be assessed for both the control group and the intervention group.

  2. Change from baseline in Subjective Health Complaints Inventory (SHC) at 12 months

    Time frame: 12 months

    This outcome measure will be assessed only for the intervention group.

  3. Change from baseline in Hopkins 's Symptom Check List (Lipman et al., 1979) at 6 months

    Time frame: 6 months

    This will be assessed for both the control group and the intervention group.

  4. Change from baseline in Hopkins 's Symptom Check List (Lipman et al., 1979) at 12 months

    Time frame: 12 months

    This outcome measure will be assessed only for the intervention group.

  5. Change from baseline in Örebro Screening for musculo-skeletal pain (Linton et al., 2011) at 6 months

    Time frame: 6 months

    This outcome measure will be assessed both for the Control Group and for the intervention group.

  6. Change from baseline in Örebro Screening for musculo-skeletal pain (Linton et al., 2011) at 12 months

    Time frame: 12 months

    This outcome measure will be assessed only for the intervention group.

Other outcomes

  1. Change from baseline in Numeric Pain Rating Scale (NPRS) at 6 months

    Time frame: 6 months

    This outcome measure will be assessed both for the Control Group and for the intervention group.

  2. Change from baseline in Numeric Pain Rating Scale (NPRS) at 12 months

    Time frame: 12 months

    This outcome measure will be assessed only for the intervention group.

  3. Change from Baseline in Oslo Social Support Scale (OSS-3) at 6 months

    Time frame: 6 months

    This outcome measure will be assessed both for the Control Group and for the intervention group.

  4. Change from Baseline in Oslo Social Support Scale (OSS-3) at 12 months

    Time frame: 12 months

    This outcome measure will be assessed only for the intervention group.

  5. Change from Baseline in Coping, (Pearlin & Schooler, 1978) at 6 months

    Time frame: 6 months

    This outcome measure will be assessed both for the Control Group and for the intervention group.

  6. Change from Baseline in Coping, (Pearlin & Schooler, 1978) at 12 months

    Time frame: 12 months

    This outcome measure will be assessed only for the intervention group.

  7. Change from Baseline in The self-esteem scale" (Rosenberg 1965) at 6 months

    Time frame: 6 months

    This outcome measure will be assessed both for the Control Group and for the intervention group.

  8. Change from Baseline in The self-esteem scale" (Rosenberg 1965) at 12 months

    Time frame: 12 months

    This outcome measure will be assessed only for the intervention group.

Sponsors and collaborators

Lead sponsor

Oslo Metropolitan University

Other

Registry information

Official study title

Norwegian Psychomotor Physiotherapy - The Effect on Quality of Life, The Feeling of Pain, Coping, Physical, Psychological and Social Functioning After the Treatment

Important dates

Study start
2014
Primary completion
2018
Study completion
2018
First posted
Nov 4, 2014
Registry last updated
Oct 6, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.